Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1. These changes are cosmetic and do not alter the study content.SummaryDifference0.2%

- Check13 days agoChange DetectedMinor UI/text tweaks were made: a glossary display option, capitalization updates for QC-related fields and No FEAR Act data, and a new revision tag (v3.4.0). These edits do not affect study content, eligibility criteria, results, or user workflow.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision history updated: added Revision v3.3.4 and removed Revision v3.3.3.SummaryDifference0.0%

- Check49 days agoChange DetectedLocations section updated: new sites across the US, Australia, and Canada were added and previous site entries were removed, altering the list of participating sites for the study. Revision: v3.3.3.SummaryDifference3%

- Check71 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing v3.3.1 in the page footer; the change is cosmetic and does not affect the study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedPublications section updated to note that publications are automatically filled from PubMed and may not be about the study (Revision: v3.3.1). The previous PubMed listing description was removed and replaced with the new wording (Revision: v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.